Research Institute of Stem Cells and Gene Technology (VRISG) is Healthcare System’s first intensive research institute. It stands as a strategic research unit in the field of biomedicine, pioneering applied research on stem cell transplantation for various incurable diseases, and promotes proactive healthcare for greater quality of life for all. By 2030, VRISG aims to become Vietnam’s leading research institute in the research, development, and application of stem cells in medical treatment.

Work conducted in various fields under VRISG’s purview, including immune cells and stem cells.
Immune cells
- Using immune-trained DC cells in liver cancer treatment
- Application of CAR-T cells for cancer treatment
Stem cells
- Building a bank and producing therapeutic drugs from umbilical cord mesenchymal stem cells; evaluating the results of application in treatments for psychomotor sequelae after traumatic brain injury, obstructive lung disease, infertility, brain paralysis, cirrhosis, osteoarthritis, etc.
- Building a bank and producing Cytokine medications from umbilical cord mesenchymal stem cell secretions and evaluating the results of applications in treatments of arthritis/osteoarthritis, rejuvenation, etc.
- Research on the application of stem cells in the treatment of neurological disorders, such as Parkinson’s, Alzheimer’s, autism, multiple sclerosis, autoimmune encephalitis, etc.
- Research on treatments using stem cell transplantation for cirrhosis, degenerative joint disease, congenital biliary atrophy, cerebral palsy, autism, diabetes, hormone deficiency, etc.
- Application of stem cells in the treatment of many complex diseases for which there is no specific drug
- Mastering new technologies in mesenchymal stem cell culture and secretion
- Generating pluripotent stem cells from milk teeth, umbilical cords, and peripheral blood
- Successfully generating cardiac muscle cells and neurons from pluripotent stem cells
- Stem cell transplantation for the treatment of incurable diseases, cancer, and multiple sclerosis (MS)
- Completing several phase II stem cell transplant trials to apply for approval: Autism, traumatic brain injury, stroke, etc.
- Conducting stem cell research for rejuvenation: Stem cell transplantation for males and females to address hormone decline and health degradation due to ageing